Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cns Pharmaceuticals Inc

CNSP
Current price
2.18 USD +0.1 USD (+4.81%)
Last closed 2.08 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 12 491 669 USD
Yield for 12 month -14.17 %
Week
Month
Year
CNSP
21.11.2021 - 28.11.2021

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Pomeranian Medical University, and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was incorporated in 2017 and is based in Houston, Texas. Address: 2100 West Loop South, Houston, TX, United States, 77027

Analytics

WallStreet Target Price

10 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures CNSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -18 614 714 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -194.51 %
PEG Ratio
Return On Equity TTM -559.54 %
Wall Street Target Price 10 USD
Revenue TTM
Book Value -0.41 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -7.6 USD
Diluted Eps TTM -7.6 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CNSP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CNSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 29.11.2022
Dividend Date

Stock Valuation CNSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.289
Price Book MRQ 0.4006

Financials CNSP

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CNSP

For 52 weeks

0.61 USD 6.43 USD
50 Day MA 1.64 USD
Shares Short Prior Month 75 152
200 Day MA 1.73 USD
Short Ratio 0.46
Shares Short 47 650
Short Percent 1.15 %